Treatment for Group B Streptococcus Wound Infection
For Group B Streptococcus wound infections, treat with high-dose intravenous penicillin G (benzylpenicillin) as first-line therapy, with ampicillin or amoxicillin as acceptable alternatives. 1
Antibiotic Selection
Group B Streptococcus (GBS) requires higher doses of penicillin than other streptococcal species due to somewhat higher minimal inhibitory concentrations 1. The organism remains highly susceptible to β-lactam antibiotics, with consistently low resistance rates globally 2.
First-Line Options:
- Benzylpenicillin (Penicillin G) - preferred agent
- Ampicillin - equally effective alternative
- Amoxicillin - oral option for less severe infections
Penicillin Allergy Alternatives:
- Vancomycin - for severe penicillin allergy 2
- Clindamycin - only if local susceptibility confirmed (increasing resistance globally) 2
- Avoid erythromycin due to widespread resistance 2
Clinical Assessment Algorithm
Determine Infection Severity:
Mild infection (all criteria present):
- Temperature <38.5°C
- Heart rate <110 beats/minute
- Erythema <5 cm beyond wound margins
- WBC <12,000 cells/µL
Moderate-to-severe infection (any present):
- Temperature >38.5°C
- Heart rate >110 beats/minute
- Erythema >5 cm beyond wound margins
- Signs of systemic toxicity
Treatment Approach:
For mild infections:
- Wound care with incision and drainage if abscess present
- Consider antibiotics only if systemic signs develop 3
For moderate-to-severe infections:
- Immediate IV antibiotics
- Surgical consultation if necrotizing infection suspected 3
- Culture wound contents to confirm GBS and guide therapy
Surgical Management
Surgical intervention is essential for successful treatment of soft tissue or bone infections caused by GBS 1. Do not rely on antibiotics alone when:
- Abscess or fluid collection present
- Necrotizing infection suspected
- Bone involvement identified
Incision and drainage combined with appropriate antibiotics provides optimal outcomes for wound infections 3.
Important Caveats
Polymicrobial infection occurs frequently with GBS wound infections 1. If the patient has risk factors for mixed flora (diabetes, immunosuppression, nosocomial acquisition), consider broader empiric coverage initially until cultures confirm GBS as sole pathogen.
GBS in wounds differs from neonatal disease - the neonatal literature emphasizes gentamicin combinations 4, 5, but this is not necessary for simple wound infections in adults where penicillin monotherapy suffices 1, 6.
Mortality risk is highest in elderly patients with invasive GBS disease 1. Aggressive early treatment is critical in this population.